Meet Sudoscan at the 12th EAN Congress 2026 in Geneva
Sudoscan is pleased to announce its participation in the 12th Congress of the European Academy of Neurology (EAN), taking place from June 27 to 30, 2026, at Palexpo in Geneva, Switzerland.
As one of the leading neurology events worldwide, the EAN Congress brings together clinicians, researchers, educators, industry partners, residents, students, and patient representatives for four days of scientific exchange and education.
This year’s congress will focus on the theme “Brains, Bytes & Beyond: Tech in Neurology”, exploring how technology, computing, and artificial intelligence are transforming neurological practice. Sudoscan will be present at stand E41 to showcase its innovative, non-invasive technology for the assessment of small fiber and autonomic neuropathies.
“Brains, Bytes & Beyond”:
The Core Theme of EAN 2026
Organized annually by the European Academy of Neurology, the EAN Congress is a major international meeting dedicated to advancing neurological science, education, and clinical practice.
The 2026 edition in Geneva will explore how technological progress is reshaping the field of neurology. From artificial intelligence and clinical decision-making to restorative therapies and new diagnostic approaches, the programme will highlight both the opportunities and challenges brought by innovation in neurological care.
Through scientific sessions, named lectures, oral presentations, ePosters, and educational activities, EAN 2026 will offer a broad overview of current developments across neurology and related disciplines.
If you want to learn more about the EAN 2026 scientific programme, click here.
Sudoscan: Supporting Neurological Care
Sudoscan is a CE-certified and FDA-cleared Class IIa medical device designed to provide a rapid and non-invasive evaluation of sudomotor function through the measurement of Electrochemical Skin Conductance (ESC).
By assessing the function of small nerve fibers, Sudoscan supports the early identification and follow-up of autonomic and peripheral neuropathies, which can be associated with various neurological and metabolic disorders.
Sudoscan’s diagnostic solution is:
● Fast: results in under 3 minutes, with no patient preparation
● Non-invasive: painless and easy to perform
● Evidence-based: supported by numerous peer-reviewed scientific publications
For more studies on the efficacy of Sudoscan’s technology in neurological diseases, visit our publications page.
Come and See Sudoscan at Stand E41
We invite neurologists, clinicians, researchers, and healthcare professionals attending EAN 2026 to visit Sudoscan at stand E41.
Join us to:
● Experience live demonstrations of the Sudoscan device
● Learn how Sudoscan supports the assessment of small fiber and autonomic dysfunction
● Discuss clinical applications and implementation strategies with our team
EAN 2026 will be a valuable opportunity to connect with the international neurology community and explore how innovative technologies can support better diagnostic pathways and patient care.
For full programme details, registration, and practical information, please visit the official EAN 2026 website.
We look forward to welcoming you in Geneva!
